Literature DB >> 10092116

Coordinate action of Wt1 and a modifier gene supports embryonic survival in the oviduct.

J A Kreidberg1, T A Natoli, L McGinnis, M Donovan, J D Biggers, A Amstutz.   

Abstract

The Wt1 gene, originally identified as a tumor suppressor gene associated with Wilms' tumors, encodes a zinc finger containing transcription factor expressed during gonadal and kidney development. Although Wt1 appears to be required for gonadal and kidney development, no reproductive defects were observed in outbred females heterozygous for a targeted mutation in Wt1. In contrast, no litters were obtained from Wt1 +/- females on a strain 129/Sv inbred genetic background. Ovaries were smaller in Wt1 +/- 129/Sv mice and produced fewer ova, but transplanted Wt1 +/- ovaries from 129/Sv females were able to support successful pregnancies. The inability of Wt1 +/- 129/Sv females to produce successful implantations after ovulation and fertilization appeared to be due to the failure of one-cell embryos to undergo mitosis, such that they were lost in the oviduct before reaching the uterus. Approximately 50% of Wt1 +/- females generated from a backcross of Wt1 +/- 129/Sv:C57BI/6 F1 hybrids to 129/Sv were fertile, indicating the presence of a Wt1 modifier gene that affects survival of the preimplantation embryo. Neither levels of WT1 protein nor the ratio of WT1 spice forms were significantly altered in Wt1 +/- reproductive organs, suggesting that this modifier effect acts downstream of WT1. Wt1 is therefore among a small subset of genes required for survival of the pre-implantation embryo, and appears to function non-autonomously.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092116     DOI: 10.1002/(SICI)1098-2795(199904)52:4<366::AID-MRD5>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

1.  A catalyst for change in reproductive science: John D. Biggers as a mentor’s mentor.

Authors:  David F Albertini; Lynda K McGinnis
Journal:  J Assist Reprod Genet       Date:  2013-08       Impact factor: 3.412

2.  A mammal-specific exon of WT1 is not required for development or fertility.

Authors:  Thomas A Natoli; Alice McDonald; Julia A Alberta; Mary E Taglienti; David E Housman; Jordan A Kreidberg
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile.

Authors:  Colin G Miles; Joan Slight; Lee Spraggon; Maureen O'Sullivan; Charles Patek; Nicholas D Hastie
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).

Authors:  Charles E Patek; David G Brownstein; Stewart Fleming; Caroline Wroe; Lorraine Rose; Anna Webb; Rachel L Berry; Paul S Devenney; Marion Walker; Oliver D K Maddocks; Nicola J Lawrence; David J Harrison; Katrina M Wood; Colin G Miles; Martin L Hooper
Journal:  Transgenic Res       Date:  2007-11-27       Impact factor: 2.788

5.  Genetic Cre-loxP assessment of epicardial cell fate using Wt1-driven Cre alleles.

Authors:  Bin Zhou; William T Pu
Journal:  Circ Res       Date:  2012-11-09       Impact factor: 17.367

6.  The Wilms tumor protein Wt1 contributes to female fertility by regulating oviductal proteostasis.

Authors:  Abinaya Nathan; Peter Reinhardt; Dagmar Kruspe; Tjard Jörß; Marco Groth; Hendrik Nolte; Andreas Habenicht; Jörg Herrmann; Verena Holschbach; Bettina Toth; Marcus Krüger; Zhao-Qi Wang; Matthias Platzer; Christoph Englert
Journal:  Hum Mol Genet       Date:  2017-05-01       Impact factor: 6.150

7.  Whole exome sequencing identified a rare WT1 loss-of-function variant in a non-syndromic POI patient.

Authors:  Yingchen Wang; Qing Chen; Feng Zhang; Xi Yang; Lingyue Shang; Shuting Ren; Yuncheng Pan; Zixue Zhou; Guoqing Li; Yunzheng Fang; Li Jin; Yanhua Wu; Xiaojin Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-11-29       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.